Endoscopic Ablation Is a Cost-Effective Cancer Preventative Therapy in Patients With Barrett’s Esophagus Who Have Elevated Genomic Instability

Endoscopy International Open
doi 10.1055/s-0042-103415
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Endoscopic Eradication Therapy for Patients With Barrett’s Esophagus–associated Dysplasia and Intramucosal Cancer

Gastrointestinal Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2018English

Cost–effectiveness Analysis of Endoscopic Eradication Therapy for Treatment of High-Grade Dysplasia in Barrett’s Esophagus

Journal of Comparative Effectiveness Research
Health Policy
2017English

Regression of Barrett’s Esophagus With Proton Pump Inhibitor Therapy

Progress of Digestive Endoscopy
2008English

A Cost-Effectiveness Analysis of an Adenocarcinoma Risk Prediction Multi-Biomarker Assay for Patients With Barrett’s Esophagus

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Adherence to Therapy for Barrett’s Esophagus-Associated Neoplasia

United European Gastroenterology Journal
OncologyGastroenterology
2015English

Barrett’s Esophagus – Who, How, How Often and What to Do With Dysplasia?

Canadian Journal of Gastroenterology
2006English

Increased Prevalence of Barrett’s Esophagus in Patients With MUTYH-associated Polyposis (MAP)

Familial Cancer
Cancer ResearchOncologyGenetics
2020English

Low-Dose Splenic Irradiation Is Effective for Patients With Hematological Diseases Who Have Symptomatic Splenomegaly

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Clopidogrel Was Effective in Patients Who Have MI With ST Segment Elevation Receiving Aspirin and Fibrinolytic Therapy

Evidence-Based Medicine
Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy